Visx' Star S2 Excimer Laser Approvable For LASIK With Conditions - Panel
This article was originally published in The Gray Sheet
Executive Summary
A July 22 recommendation that Visx' Star S2 excimer laser be approved for in situ keratomileusis (LASIK) procedures was precipitated by a consensus desire on the part of FDA's Ophthalmic Devices Panel to disseminate study data through product labeling.
You may also be interested in...
Summit Able To Promote Apex Plus For LASIK At Ophthalmology Conference
Summit Technology's receipt on Oct. 21 of FDA approval for its Apex Plus excimer laser for use in laser-assisted in-situ keratomileusis (LASIK) could help the firm increase its market share by 30%, the firm says. Analysts estimate the firm's stake at 20%.
Summit Able To Promote Apex Plus For LASIK At Ophthalmology Conference
Summit Technology's receipt on Oct. 21 of FDA approval for its Apex Plus excimer laser for use in laser-assisted in-situ keratomileusis (LASIK) could help the firm increase its market share by 30%, the firm says. Analysts estimate the firm's stake at 20%.
Staar Surgical To Offer Ophthalmic Surgeons Stake In Laser-Center Chain
Staar Surgical will allow certain ophthalmic surgeons to purchase an equity stake in its chain of refractive laser eye surgery centers, the firm says.